Skip to content

Drug interactions

Deferiprone + Idelalisib

Severity: Major

Deferiprone and Idelalisib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Idelalisib commonly causes neutropenia, sometimes severe. Together with deferiprone, which can cause agranulocytosis, the risk of serious infection is increased.

What this interaction means in plain words

Deferiprone and Idelalisib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Deferiprone belongs to Miscellaneous; Idelalisib belongs to Oncology.

Evidence level: Low

Why it happens

Additive neutropenic effects.

What to do

Avoid if an alternative exists; otherwise monitor absolute neutrophil count frequently and interrupt deferiprone if neutropenia develops.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deferiprone and Idelalisib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deferiprone with Idelalisib?

MediHelp rates the interaction as major. Deferiprone and Idelalisib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Idelalisib commonly causes neutropenia, sometimes severe. Together with deferiprone, which can cause agranulocytosis, the risk of serious infection is increased.

How serious is the interaction between Deferiprone and Idelalisib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if an alternative exists; otherwise monitor absolute neutrophil count frequently and interrupt deferiprone if neutropenia develops.

What other medicines interact with Deferiprone?

MediHelp also lists interactions of Deferiprone with, for example, Clozapine, Abemaciclib, Acalabrutinib. The full list is on the Deferiprone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in